Bethany Van Guelpen

researcher

Born 1979-01-01

Bethany Van Guelpen is …
instance of (P31):
humanQ5

External links are
P269IdRef ID195811267
P5587Libris-URIwt7bfpsf0hsphfs
P496ORCID iD0000-0002-9692-101X
P3829Publons author ID2374916
P1053ResearcherIDJ-8159-2015
P906SELIBR ID277543
P214VIAF ID12289409

P735given nameBethanyQ3639114
BethanyQ3639114
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q104471089A combined proteomics and Mendelian randomization approach to investigate the effects of aspirin-targeted proteins on colorectal cancer
Q90633417A longitudinal study of prediagnostic metabolic biomarkers and the risk of molecular subtypes of colorectal cancer
Q36159102A traditional Sami diet score as a determinant of mortality in a general northern Swedish population
Q57419283Anthropometry, physical activity and hip fractures in the elderly
Q93085607Antibody Responses to Fusobacterium nucleatum Proteins in Prediagnostic Blood Samples are not Associated with Risk of Developing Colorectal Cancer
Q93213974Antibody responses to Helicobacter pylori and risk of developing colorectal cancer in a European cohort
Q52875254Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk.
Q115037634Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis
Q58352160Blood sample collection and patient identification demand improvement: a questionnaire study of preanalytical practices in hospital wards and laboratories
Q90758064Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease
Q40310151Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC).
Q92128555C-reactive protein and future risk of clinical and molecular subtypes of colorectal cancer
Q114997669Cancer Worry Distribution and Willingness to Undergo Colonoscopy at Three Levels of Hypothetical Cancer Risk—A Population-Based Survey in Sweden
Q46097547Cigarette smoking and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition study
Q91595645Circulating levels of inflammatory markers and DNA methylation, an analysis of repeated samples from a population based cohort
Q39585082Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion
Q38412549Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor
Q39639259Components of One-carbon Metabolism Other than Folate and Colorectal Cancer Risk
Q50187031Consumption and portion sizes of tree nuts, peanuts and seeds in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts from 10 European countries
Q59587906Consumption of filtered and boiled coffee and the risk of first acute myocardial infarction; a nested case/referent study
Q39868237Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study
Q93118070Correction to: Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer
Q91828047Dairy Products and Cancer Risk in a Northern Sweden Population
Q39743705Diet and lifestyle of the Sami of southern Lapland in the 1930s--1950s and today
Q51914315Dietary intake of different types and characteristics of processed meat which might be associated with cancer risk--results from the 24-hour diet recalls in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Q60472142Discovery of common and rare genetic risk variants for colorectal cancer
Q43248937Eating out of home: energy, macro- and micronutrient intakes in 10 European countries. The European Prospective Investigation into Cancer and Nutrition.
Q34582313Folate in colorectal cancer, prostate cancer and cardiovascular disease.
Q46525412Folate, vitamin B12, and risk of ischemic and hemorrhagic stroke: a prospective, nested case-referent study of plasma concentrations and dietary intake
Q63976721Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer
Q53215560High SMAD4 levels appear in microsatellite instability and hypermethylated colon cancers, and indicate a better prognosis.
Q36683862High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis
Q91889338Identification of Novel Loci and New Risk Variant in Known Loci for Colorectal Cancer Risk in East Asians
Q98574004Intake of dietary fruit, vegetables, and fiber and risk of colorectal cancer according to molecular subtypes: A pooled analysis of 9 studies
Q56836039Iron Stores and HFE Genotypes Are Not Related to Increased Risk of Ischemic Stroke
Q53271926Iron biomarkers in plasma, HFE genotypes, and the risk for colorectal cancer in a prospective setting.
Q97595643Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival
Q34581206Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC).
Q59587890Low Folate Levels Are Associated with Reduced Risk of Colorectal Cancer in a Population with Low Folate Status
Q36846778Low-carbohydrate, high-protein diet score and risk of incident cancer; a prospective cohort study
Q44070839Low-carbohydrate, high-protein score and mortality in a northern Swedish population-based cohort
Q90913355Metabolic factors and the risk of colorectal cancer by KRAS and BRAF mutation status
Q43891337North-south gradients in plasma concentrations of B-vitamins and other components of one-carbon metabolism in Western Europe: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study
Q38418708One-carbon metabolism and CpG island methylator phenotype status in incident colorectal cancer: a nested case-referent study
Q46021239One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites.
Q55362939One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status.
Q88768351One-carbon metabolite ratios as functional B-vitamin markers and in relation to colorectal cancer risk
Q48384597Patient-centred care--preanalytical factors demand attention: a questionnaire study of venous blood sampling and specimen handling
Q89454638Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
Q44391519Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function
Q33894035Plasma folate, related genetic variants, and colorectal cancer risk in EPIC.
Q40473846Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study.
Q55050221Plasma miRNA can detect colorectal cancer, but how early?
Q43958842Plasma vitamin B12 concentrations and the risk of colorectal cancer: a nested case-referent study
Q53303253Polymorphisms in fatty-acid-metabolism-related genes are associated with colorectal cancer risk.
Q46865322Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case-control study
Q99408786Postmenopausal Hormone Therapy and Colorectal Cancer Risk by Molecularly Defined Subtypes and Tumor Location
Q58352237Preanalytical venous blood sampling practices demand improvement — A survey of test-request management, test-tube labelling and information search procedures
Q56836005Prospective study of first stroke in relation to plasma homocysteine and MTHFR 677C>T and 1298A>C genotypes and haplotypes – evidence for an association with hemorrhagic stroke
Q41667667Subtypes of fruit and vegetables, variety in consumption and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition
Q48112602Targeted plasma proteomics identifies a novel, robust association between cornulin and Swedish moist snuff.
Q59587939The MTHFR 677C→T polymorphism and risk of prostate cancer: results from the CAPS study
Q37738141The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples
Q33849485The association of education with body mass index and waist circumference in the EPIC-PANACEA study
Q46144972The reduced folate carrier (RFC1) 80G > A and folate hydrolase 1 (FOLH1) 1561C > T polymorphisms and the risk of colorectal cancer: a nested case-referent study
Q38417609The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status
Q37663064Untangling the role of one-carbon metabolism in colorectal cancer risk: a comprehensive Bayesian network analysis
Q53452046Vitamin B-6 and colorectal cancer risk: a prospective population-based study using 3 distinct plasma markers of vitamin B-6 status.
Q42743285c-Met expression in primary tumors and their corresponding distant metastases

Search more.